| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2024-10-02 | Lebovits Chaim President & CEO | Purchase | +23,836 | -93.05%80,960 | $0.47 | $11,308 | View SEC filing | |
| 2024-07-31 | Lebovits Chaim President & CEO | Purchase | +15,000 | +1.30%1,164,865 | $0.52 | $7,775 | View SEC filing | |
| 2024-07-31 | Lebovits Chaim President & CEO | Purchase | +50,000 | +4.55%1,149,865 | $0.61 | $30,475 | View SEC filing | |
| 2024-07-31 | Lebovits Chaim President & CEO | Purchase | +40,000 | +3.77%1,099,865 | $0.47 | $18,865 | View SEC filing | |
| 2024-07-31 | Lebovits Chaim President & CEO | Purchase | +66,300 | +6.67%1,059,865 | $0.37 | $24,816 | View SEC filing | |
| 2024-07-31 | Lebovits Chaim President & CEO | Purchase | +135,000 | +15.72%993,565 | $0.38 | $50,666 | View SEC filing | |
| 2024-07-31 | Lebovits Chaim President & CEO | Purchase | +15,000 | +1.78%858,565 | $0.52 | $7,799 | View SEC filing | |
| 2024-07-31 | Lebovits Chaim President & CEO | Purchase | +245,072 | +40.95%843,565 | $0.54 | $131,411 | View SEC filing | |
| 2024-07-24 | Dagher Ibrahim B. Chief Medical Officer | Sale | -63,000 | -100.00%0 | $0.35 | $22,069 | View SEC filing | |
| 2023-09-05 | Lindborg Stacy Co-Chief Executive Officer | Purchase | +11,500 | +6.76%181,500 | $1.77 | $20,402 | View SEC filing | |
| 2020-11-19 | Lindborg Stacy EVP, Head Global Clin Research | Purchase | +20,000 | +100.00%20,000 | $110.00 | $2,200,000 | View SEC filing | |
| 2020-07-16 | Abbhi Sankesh Director | Purchase | +46,779 | +2.21%2,164,530 | $12.99 | $607,659 | View SEC filing | |
| 2020-07-16 | Setboun David EVP and COO | Purchase | +5,000 | +10.00%55,000 | $12.95 | $64,740 | View SEC filing | |
| 2020-07-16 | ACC International Holdings Ltd. Other | Sale | -71,753 | -51.69%67,053 | $13.39 | $960,656 | View SEC filing | |
| 2019-12-27 | Kern Ralph Dr. COO and Chief Medical Officer | Purchase | +3,000 | +2.66%115,655 | $3.88 | $11,640 | View SEC filing | |
| 2019-12-27 | Shah Preetam EVP, CFO and Treasurer | Purchase | +11,600 | +46.40%36,600 | $3.96 | $45,929 | View SEC filing | |
| 2019-12-27 | Araya Arturo Chief Commercial Officer | Purchase | +3,000 | +53.50%8,608 | $3.90 | $11,700 | View SEC filing | |
| 2019-08-30 | ARBEL IRIT Director | Sale | -13,332 | -7.88%155,833 | $3.67 | $48,891 | View SEC filing | |
| 2019-01-08 | Almenoff June Sherie Director | Purchase | +1,475 | +25.88%7,175 | $3.39 | $5,000 | View SEC filing | |
| 2018-03-20 | Almenoff June Sherie Director | Purchase | +5,700 | +100.00%5,700 | $3.50 | $19,950 | View SEC filing | |
| 2018-03-20 | Kern Ralph Dr. COO and Chief Medical Officer | Purchase | +5,000 | +13.93%40,885 | $3.60 | $17,997 | View SEC filing | |
| 2017-08-31 | ARBEL IRIT Director | Purchase | +2,500 | +1.63%155,833 | $4.26 | $10,650 | View SEC filing | |
| 2017-08-23 | Yablonka Uri EVP & Chief Business Officer | Purchase | +2,000 | +36.08%7,543 | $3.98 | $7,960 | View SEC filing | |
| 2015-12-17 | SHORR ROBERT G L Director | Sale | -10,800 | -27.55%28,399 | $2.71 | $29,268 | View SEC filing | |
| 2015-12-16 | Friedman Mordechai Director | Sale | -5,000 | -100.00%0 | $2.57 | $12,850 | View SEC filing |
1-25 of 69
